Publications & Research

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

This study found that screening with the use of low-dose CT reduces mortality from lung cancer.  The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening. The advent of low-dose helical computed tomography (CT) altered the landscape of lung-cancer screening, with studies indicating that low-dose CT detects many tumors at early stages. The National Lung Screening Trial (NLST) was conducted to determine whether screening with low-dose CT could reduce mortality from lung cancer.

Click here to view the full study.